You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

21-228

Showing 1 - 25 of 5,742
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +65 more
Aug 19, 2022

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
Has Results
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Type 2 Diabetes Trial in Ankara (Type 2 Diabetes Diet Modification)

Completed
  • Type 2 Diabetes
  • Type 2 Diabetes Diet Modification
  • Ankara, Turkey
  • +1 more
Jul 10, 2023

Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg

Active, not recruiting
Has Results
  • Metastatic Triple Negative Breast Cancer
  • Olaparib Continuous (28-Day cycle) 300 mg BD.
  • +2 more
  • Birmingham, Alabama
  • +140 more
Nov 17, 2022

Behçet's Syndrome Trial in Worldwide (Apremilast, Placebo)

Completed
Has Results
  • Behçet's Syndrome
  • Phoenix, Arizona
  • +62 more
Jul 2, 2021

Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)

Terminated
Has Results
  • Soft-tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 19, 2022

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)

Completed
Has Results
  • Type 2 Diabetes
  • Blacktown, New South Wales, Australia
  • +66 more
Dec 12, 2022

Safety Markers of Adjuvanted Influenza Vaccine Trial in Ghent (Fluad, Saline)

Completed
  • Safety Markers of Adjuvanted Influenza Vaccine
  • Fluad
  • Saline
  • Ghent, East-Flanders, Belgium
    Center for Vaccinology
Dec 19, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Lenvatinib, Pembrolizumab, Docetaxel)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Duarte, California
  • +87 more
Aug 18, 2022

Mild Cognitive Impairment, Fall Trial in Taipei (Exercise, Computerized training)

Recruiting
  • Mild Cognitive Impairment
  • Fall
  • Exercise
  • Computerized training
  • Taipei, Taiwan
    Taipei Medical University
Sep 28, 2022

Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Advanced Solid Tumor
  • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
  • Tegafur Only Product
  • Petaling Jaya, Kuala Lumpur, Malaysia
    Clinical Oncology Department, Ummc
Jul 12, 2023

Vitamin D, HbA1c and Vitamin B12 Levels in Patients

Completed
  • Serum HbA1c and Vitamin D, Vitamin B12 Values in Periodontal Diseases
  • HbA1c, Vitamin D, Vitamin B12
  • Niğde, Turkey
    Nigde Omer Halisdemir University, Dentistry Faculty, Periodontol
Feb 23, 2023

Asthma Trial in Worldwide (MEDI3506, Placebo)

Active, not recruiting
  • Asthma
  • MEDI3506
  • Placebo
  • Bakersfield, California
  • +64 more
Dec 19, 2022

Rosacea Trial in Worldwide (CLS001 (Omiganan), Vehicle)

Completed
Has Results
  • Rosacea
  • Fremont, California
  • +40 more
Jul 31, 2022

Lung Cancer Trial in Worldwide (Pembrolizumab, Epacadostat, Platinum-based chemo)

Completed
Has Results
  • Lung Cancer
  • Daphne, Alabama
  • +93 more
Jan 19, 2022

Health, Subjective, Inflammatory Response, Adverse Effect Trial in Puerto Rico, United States (Cannabigerol)

Enrolling by invitation
  • Health, Subjective
  • +3 more
  • Cannabigerol
  • Arlington, Texas
  • +6 more
Feb 23, 2023

Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine

Recruiting
  • Triple Negative Breast Cancer
  • Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
  • Gemcitabine combined with carboplatin plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 6, 2022

Schizophrenia Trial in Worldwide (LY2140023, Placebo)

Terminated
Has Results
  • Schizophrenia
  • Wichita, Kansas
  • +12 more
Sep 21, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +123 more
Jun 15, 2022

Pain Management Trial in Baghdad (Non-pharmacological pain management strategies)

Completed
  • Pain Management
  • Non-pharmacological pain management strategies
  • Baghdad, Iraq
    College of Nursing- The University of Baghdad
Jul 12, 2023

Type 1 Diabetes Trial in Worldwide (Insulin glargine,300 U/mL, Insulin glargine (100 units /mL), Background therapy)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Insulin glargine,300 U/mL
  • +2 more
  • Tucson, Arizona
  • +106 more
Mar 15, 2022

Paternal Age and Fetal Aneuploidy

Active, not recruiting
  • Trisomy 21
  • Optimo prenatal screening test
  • Montréal, Quebec, Canada
    Clinique Ovo
Aug 7, 2023

Ovarian Cancer Trial in Milwaukee (Pembrolizumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Milwaukee, Wisconsin
    Medical College of Wisconsin and Froedtert Hospital
Apr 7, 2022

Malaria Trial in Worldwide (Pyronaridine artesunate, Chloroquine)

Completed
Has Results
  • Malaria
  • Pailin, Pailin Province, Cambodia
  • +4 more
Oct 22, 2021